MONTREAL, Dec. 11,
2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the
"Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a
vertically integrated producer of premium-grade cannabis and
derivative products with one of the largest indoor cannabis
cultivation facilities in Canada, and the largest
in Quebec, today announced that it will host a webcast
investor presentation on Thursday, December 14th,
2023, at 2:00 PM ET. During the webcast, Nicholas Sosiak,
CFO, will conduct a presentation that will cover key areas of
Cannara's business. After the formal presentation, investors will
have an opportunity to ask relevant questions through an
interactive Q&A session. To listen to the webcast or to ask
questions during the live event, please pre-register at the
following link:
Webcast
Link: https://us02web.zoom.us/webinar/register/WN_5lrw8pOPReWn1iIFJm7hog
An archived version of the webcast and presentation will be
available on the Company's
website, https://investors.cannara.ca/
About Cannara Biotech
Inc.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA:
8CB) is a vertically integrated producer of affordable
premium-grade cannabis and cannabis-derivative products for the
Canadian markets. Cannara owns two mega facilities based in Québec
spanning over 1,650,000 sq. ft., providing the Company with
100,000kg of potential annualized cultivation output. Leveraging
Québec's low electricity costs, Cannara's facilities produce
premium-grade cannabis products at an affordable price. For more
information, please visit cannara.ca.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Cautionary Statement Regarding
"Forward-Looking" Information
This information release contains certain forward-looking
information. Such information involves known and unknown risks,
uncertainties and other factors that may cause actual results,
performance, or achievements to be materially different from those
implied by statements herein, and therefore these statements should
not be read as guarantees of future performance or results. All
forward-looking statements are based on the Company's current
beliefs as well as assumptions made by and information currently
available to it as well as other factors. Readers are cautioned not
to place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. Due to risks and
uncertainties, including the risks and uncertainties identified by
the Company in its public securities filings, actual events may
differ materially from current expectations. The Company disclaims
any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cannara-biotech-to-host-investor-webcast-on-thursday-december-14th-2023-302010919.html
SOURCE Cannara Biotech Inc.